Assessment of Keratitis Severity Using Quantitative Image Analysis in an In Vivo Murine Model of Staphylococcus aureus Bacterial Keratitis.
Journal
Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
entrez:
16
11
2022
pubmed:
17
11
2022
medline:
19
11
2022
Statut:
ppublish
Résumé
Bacterial keratitis (BK) severity in murine models has traditionally been measured by subjective clinical grading or quantification of ocular bacterial burden. This investigation explores an objective and repeatable quantification of slit lamp photography (SLP) images to measure BK severity. BALB/c strain mice underwent three parallel scratches of the right cornea with subsequent inoculation of 107Staphylococcus aureus cells. SLP imaging and clinical severity grading were performed at 48 hours post-infection. Stromal infiltrate (SI) area on SLP images were quantified. Bacterial burden was determined after enucleation and homogenization. Spearman rank correlations (rs) were used to estimate associations between SI area, clinical severity grades, and bacterial burden. BALB/c strain mice (n = 14) were evaluated with an average SI area of 0.92 mm2 (standard deviation, SD = 0.65) and average bacterial burden of 3.16 × 105 colony forming units per milliliter (CFU/mL) (SD = 8.3 × 105). Clinical severity grade positively correlated with SI area (rs = 0.59, p = 0.0276) and bacterial burden (rs = 0.66, p = 0.0106). There was a trend towards positive association between SI area and bacterial burden (rs = 0.51, p = 0.0543). SLP annotation of SI area is correlated with clinical severity and may provide an objective, quantitative, and repeatable assessment of BK disease severity. SLP annotation of SI area is a novel quantitative method to evaluate bacterial keratitis severity longitudinally in mouse models which may be a powerful tool to better understand BK pathogenesis and response to treatments.
Identifiants
pubmed: 36383392
pii: 2783865
doi: 10.1167/tvst.11.11.12
pmc: PMC9680585
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
12Subventions
Organisme : NEI NIH HHS
ID : R01 EY031033
Pays : United States
Organisme : NEI NIH HHS
ID : K08 EY029012
Pays : United States
Références
Eye (Lond). 2003 Nov;17(8):957-74
pubmed: 14631403
Clin Infect Dis. 2013 Jun;56(12):1713-21
pubmed: 23487367
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3648-54
pubmed: 19264894
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30420484
Invest Ophthalmol Vis Sci. 1987 Dec;28(12):1978-85
pubmed: 3119512
Cornea. 2018 Jan;37(1):84-87
pubmed: 29053557
Immunol Cell Biol. 2005 Jun;83(3):294-300
pubmed: 15877608
Ophthalmology. 1992 Feb;99(2):215-21
pubmed: 1553210
Acad Radiol. 2004 Feb;11(2):178-89
pubmed: 14974593
Cornea. 2018 Mar;37(3):331-339
pubmed: 29256985
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2064-70
pubmed: 15914624
Ophthalmology. 2021 Oct;128(10):e51-e68
pubmed: 34247850
J Immunol. 2020 Jan 1;204(1):169-179
pubmed: 31767781
Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2786-95
pubmed: 22467580
Eye (Lond). 2011 Apr;25(4):489-93
pubmed: 21252952
Invest Ophthalmol Vis Sci. 2012 May 31;53(6):3120-5
pubmed: 22499983
Arch Ophthalmol. 2009 Feb;127(2):161-6
pubmed: 19204233
Bull World Health Organ. 2001;79(3):214-21
pubmed: 11285665
J Infect Dis. 2014 Jul 1;210(1):89-98
pubmed: 24403554
Cornea. 2020 Dec;39(12):1503-1509
pubmed: 32833849
Infect Immun. 1997 Jul;65(7):2754-8
pubmed: 9199446